Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
19.28
Dollar change
-0.08
Percentage change
-0.41
%
Index- P/E20.98 EPS (ttm)0.92 Insider Own0.07% Shs Outstand586.83M Perf Week1.15%
Market Cap11.31B Forward P/E10.21 EPS next Y1.89 Insider Trans0.00% Shs Float586.39M Perf Month-0.16%
Income539.36M PEG20.57 EPS next Q0.28 Inst Own5.65% Short Float0.23% Perf Quarter-8.37%
Sales21.03B P/S0.54 EPS this Y6.79% Inst Trans- Short Ratio2.95 Perf Half Y-10.78%
Book/sh25.64 P/B0.75 EPS next Y26.70% ROA1.43% Short Interest1.33M Perf Year-6.68%
Cash/sh2.90 P/C6.65 EPS next 5Y1.02% ROE3.60% 52W Range16.37 - 27.72 Perf YTD-7.44%
Dividend Est.0.60 (3.10%) P/FCF5.38 EPS past 5Y-24.77% ROI2.03% 52W High-30.43% Beta1.00
Dividend TTM0.60 (3.14%) Quick Ratio1.02 Sales past 5Y1.53% Gross Margin25.32% 52W Low17.78% ATR (14)0.48
Dividend Ex-DateMay 13, 2022 Current Ratio1.40 EPS Y/Y TTM-23.71% Oper. Margin8.41% RSI (14)47.20 Volatility1.53% 1.77%
Employees119845 Debt/Eq0.88 Sales Y/Y TTM3.14% Profit Margin2.56% Recom3.05 Target Price21.02
Option/ShortYes / Yes LT Debt/Eq0.77 EPS Q/Q42.59% Payout34.42% Rel Volume0.45 Prev Close19.36
Sales Surprise0.67% EPS Surprise8.92% Sales Q/Q5.24% EarningsFeb 20 BMO Avg Volume449.48K Price19.28
SMA20-1.43% SMA50-2.16% SMA200-9.45% Trades Volume204,404 Change-0.41%
Date Action Analyst Rating Change Price Target Change
Jan-08-24Downgrade Morgan Stanley Equal-Weight → Underweight
Nov-24-23Upgrade HSBC Securities Reduce → Hold
Nov-17-23Upgrade Societe Generale Hold → Buy
Aug-14-23Downgrade UBS Buy → Neutral
Aug-01-23Resumed Citigroup Neutral
Jul-12-23Initiated Goldman Buy
Mar-07-23Initiated Bernstein Mkt Perform
Jan-03-23Downgrade Jefferies Buy → Underperform $14 → $11.70
Oct-26-22Downgrade Deutsche Bank Hold → Sell
Oct-18-22Initiated Morgan Stanley Equal-Weight
Mar-25-24 11:10AM
10:59AM
10:46AM
Mar-22-24 08:00AM
Mar-19-24 08:00AM
10:14AM Loading…
Mar-15-24 10:14AM
Mar-11-24 09:42AM
Mar-06-24 05:02PM
Mar-05-24 03:34PM
10:10AM
10:09AM
Feb-21-24 09:36AM
02:49AM
Feb-20-24 01:10PM
07:30AM
01:44AM Loading…
01:44AM
Feb-17-24 03:19AM
Feb-08-24 08:54AM
Feb-05-24 08:57AM
Jan-08-24 08:16AM
Dec-06-23 09:52AM
Nov-30-23 07:00AM
Nov-27-23 08:13PM
Nov-23-23 06:47AM
Nov-22-23 08:28AM
Nov-21-23 04:07PM
Nov-10-23 08:52AM
Nov-08-23 04:00AM
Nov-03-23 09:34AM
08:54AM
01:34PM Loading…
Nov-02-23 01:34PM
12:36PM
02:38AM
Nov-01-23 06:15PM
05:33PM
07:46AM
Oct-31-23 07:12PM
09:28AM
08:00AM
Oct-30-23 12:36AM
Oct-26-23 09:58AM
Oct-24-23 02:18AM
01:22AM
Oct-23-23 05:59PM
10:15AM
09:15AM
Oct-20-23 09:40AM
Oct-18-23 08:00AM
Oct-16-23 07:17AM
Oct-12-23 12:55PM
12:18PM
11:53AM
Oct-11-23 01:56PM
12:18PM
12:06PM
11:52AM
11:39AM
11:25AM
10:33AM
08:00AM
06:02AM
Oct-04-23 08:29PM
Sep-15-23 08:20AM
Sep-06-23 10:28AM
Aug-24-23 08:43AM
Aug-23-23 09:01AM
Aug-09-23 09:00AM
Aug-03-23 10:55AM
Aug-02-23 05:56PM
09:45AM
05:03AM
Aug-01-23 09:02AM
Jul-14-23 02:32PM
11:34AM
Jul-13-23 02:26AM
Jul-10-23 09:00AM
Jun-10-23 03:45AM
Jun-07-23 02:31AM
May-27-23 03:16AM
May-13-23 02:17AM
May-10-23 11:39AM
May-09-23 03:48PM
05:04AM
May-08-23 02:10AM
May-04-23 12:29AM
Apr-19-23 01:46PM
Apr-10-23 09:43AM
Apr-03-23 08:40PM
Mar-22-23 01:00PM
Mar-13-23 08:00AM
Mar-06-23 08:00AM
Feb-23-23 11:16PM
04:33PM
09:45AM
Feb-22-23 12:46PM
12:08PM
Feb-21-23 11:42PM
02:12PM
01:47PM
10:06AM
Fresenius Medical Care AG engages in the provision of products and services for individuals with renal diseases. It operates through the Care Enablement and Care Delivery segments. The Care Enablement segment is involved in the healthcare products business including research and development, manufacturing, supply chain, and commercial operations as well as supporting functions, such as regulatory and quality management. The Care Delivery segment focuses on the health care services for the treatment of CKD, ESRD, and other extracorporeal therapies, including value and risk-based care programs. The company was founded on August 5, 1996 and is headquartered in Bad Homburg, Germany.